GlassScriptPhysician profile
Morgan Mills
NPI 1891359154
$4,193.46
in general payments reported to CMS, 2019-2025
11 companies · $2,920 in 2025
The $2,920 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $223 · 2023: $874 · 2024: $177 · 2025: $2,920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,584 · Travel and Lodging: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.92 |
| Travel and Lodging | $1,386.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,040.80 | 2023-2025 | Inspire |
| Integra Lifesciences Corporation | $717.60 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merz North America, INC. | $331.34 | 2023 | Xeomin |
| Stryker Corporation | $212.29 | 2022-2025 | Core, Latera |
| Medtronic, INC. | $207.03 | 2023-2024 | Fusion, Propel, Stealthstation S8 Platform |
| Abbvie INC. | $205.77 | 2025 | |
| Depuy Synthes Sales INC. | $182.16 | 2025 | Trumatch, Rapidsorb |
| Advanced Bionics, LLC | $144.17 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Checkpoint Surgical, INC | $98.68 | 2023 | Checkpoint Stimulators |
| Neurent Medical Limited | $33.21 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Olympus America INC. | $20.41 | 2024 | Rhino-Laryngo Videoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.